Virtus LifeSci Biotech Cl... (BBC)

NYSEArca: BBC · Echtzeitkurs · USD

53.81

+0.55 (1.03%)

Zum Schluss: Aug 18, 2026, 3:59 PM

1.03% (1D)

Geld	n/a
Marktkapitalisierung	n/a
Umsatz (TTM)	n/a
Nettogewinn (TTM)	n/a
Beta	n/a
EPS (ttm)	n/a
KGV (TTM)	n/a
Forward-KGV	n/a
KBV (TTM)	n/a
KUV (TTM)	n/a
Earnings Date	n/a

Brief	n/a
Volumen	6,708
Ø Vol. (20D)	22,956
Eröffnung	53.47
Vortagesschluss	53.26
Tagesspanne	53.18 - 53.81
52-Wk Range	21.83 - 54.95
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über BBC

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval....

[Mehr lesen]

Branche n/a

Sektor n/a

IPO Datum Dec 17, 2014

Mitarbeiter n/a

Börse NYSEArca

Tickersymbol BBC

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr undefined betrug der Umsatz von Virtus LifeSci Biotech Clinical Trials ETF n/a, ein Anstieg von undefined% im Vergleich zum Vorjahr (n/a). Der Gewinn lag bei n/a, ein Anstieg von undefined %.

Finanzberichte

Nachrichten

vor 3 Wochen · MarketBeat

Innovative ETF Strategies That Are Paying Off This Summer

Amid record ETF inflows, niche funds like BBC, LATR, and FMED offer targeted exposure to biotech trials, buy-now-pay-later firms, and disruptive medicine, with notable recent returns.